Status:

WITHDRAWN

Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder

Lead Sponsor:

New York State Psychiatric Institute

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Attention Deficit Disorder With Hyperactivity

Eligibility:

All Genders

6+ years

Phase:

NA

Brief Summary

This three-phase study will develop and test a provider-administered intervention to improve medication adherence and promote sustained medication use among children with ADHD and their caregivers.

Detailed Description

Attention deficit hyperactivity disorder (ADHD) is a common childhood behavior disorder that causes impaired functioning in multiple settings, including home, school, and in relationships with peers. ...

Eligibility Criteria

Inclusion

  • PHASE I:
  • Parent Focus Group Participants:
  • Must be primary caregiver and legal guardian of child (6-10 years) at time of initial ADHD diagnosis
  • Child must have been diagnosed with ADHD within the last 18 months at Schneider Children's Hospital's (SCH) outpatient clinic (co-morbid diagnosis of oppositional defiant disorder \[ODD\] or conduct disorder \[CD\] is permitted)
  • Provider Focus Group Participants:
  • Child psychiatrist employed by North Shore - Long Island Jewish child psychiatry outpatient department
  • Licensed to practice in New York State
  • Has more than 1 year of experience prescribing medication to youth with ADHD
  • Child Interview Participants:
  • Diagnosis of ADHD (co-morbid diagnosis of ODD, CD, or mood disorder is permitted)
  • Between 6 and 10 years old at time of initial ADHD diagnosis
  • Diagnosis occurred within 18 months prior to study entry at Zucker Hillside Hospital outpatient clinic

Exclusion

  • Parent Focus Group Participants and Child Interview Participants:
  • Child has significant co-morbid medical conditions, such as diabetes, cystic fibrosis, or severe asthma, resulting in more than 2 emergency visits in the last year
  • Child has a co-morbid diagnosis of psychosis, bipolar disorder, or other serious psychiatric condition within 12 months prior to study entry
  • Child has history of psychiatric hospitalization within 12 months prior to study entry
  • Child is receiving treatment in a different setting
  • PHASE II:
  • Inclusion Criteria:
  • Primary caregiver and legal guardian of child (6-10 years) at the time of initial ADHD diagnosis
  • Child has been diagnosed with ADHD within the last 18 months at SCH's outpatient clinic

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00429221

Start Date

January 1 2006

Last Update

April 23 2013

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.